A detailed history of Key F Inancial Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Key F Inancial Inc holds 7,717 shares of AZN stock, worth $508,395. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,717
Previous 7,711 0.08%
Holding current value
$508,395
Previous $601,000 -0.0%
% of portfolio
0.13%
Previous 0.15%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$76.67 - $87.62 $460 - $525
6 Added 0.08%
7,717 $601,000
Q2 2024

Jul 29, 2024

SELL
$66.81 - $80.83 $42,424 - $51,327
-635 Reduced 7.61%
7,711 $601,000
Q1 2024

May 13, 2024

SELL
$61.03 - $69.57 $101,187 - $115,347
-1,658 Reduced 16.57%
8,346 $565,000
Q4 2023

Jan 31, 2024

BUY
$61.89 - $69.28 $12,378 - $13,856
200 Added 2.04%
10,004 $673,000
Q3 2023

Nov 01, 2023

BUY
$64.85 - $71.7 $518 - $573
8 Added 0.08%
9,804 $663,000
Q2 2023

Jul 28, 2023

BUY
$69.91 - $75.81 $16,708 - $18,118
239 Added 2.5%
9,796 $701,000
Q1 2023

May 02, 2023

BUY
$63.15 - $71.6 $947 - $1,074
15 Added 0.16%
9,557 $663,000
Q3 2022

Oct 28, 2022

SELL
$53.02 - $135.75 $20,465 - $52,399
-386 Reduced 3.89%
9,542 $523,000
Q1 2022

Apr 27, 2022

BUY
$55.72 - $67.12 $56,611 - $68,193
1,016 Added 11.4%
9,928 $659,000
Q3 2021

Nov 01, 2021

BUY
$55.56 - $60.79 $2,611 - $2,857
47 Added 0.53%
8,912 $535,000
Q2 2021

Aug 02, 2021

BUY
$48.42 - $60.18 $342,668 - $425,893
7,077 Added 395.81%
8,865 $507,000
Q1 2021

Apr 30, 2021

BUY
$47.16 - $54.44 $943 - $1,088
20 Added 1.13%
1,788 $89,000
Q4 2020

Jan 29, 2021

BUY
$48.52 - $58.02 $85,783 - $102,579
1,768 New
1,768 $88,000
Q2 2020

Aug 07, 2020

SELL
$43.1 - $55.31 $137,532 - $176,494
-3,191 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$37.79 - $51.33 $120,587 - $163,794
3,191 New
3,191 $142,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $204B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.